Autologous bone marrow derived mononuclear cells combined with β-tricalcium phosphate and absorbable atelocollagen for a treatment of aneurysmal bone cyst of the humerus in child

Aneurysmal bone cyst is a benign, locally destructive lesion of bone. Based on progressive cortical thinning pathological fractures are common, and are often the presenting feature. Despite the long experience of orthopaedists, radiologists and pathologists with aneurysmal bone cyst there is limited knowledge regarding the cause of the lesion and optimal treatment. Common methods of treatment vary considerably in the literature, particularly in children. A large variety of bone substitutes have been used to fill the cystic lesions. To date there has been no graft material which can be regarded as completely satisfactory. Our experience with freshly isolated autologous bone marrow derived mononuclear cells combined with β-tricalcium phosphate and absorbable atelocollagen for bone formation is presented. The concept of this treatment is based on stimulation of natural events continuously present in living bone appear to be a reasonable and beneficial alternative to promote healing of bone cysts and offering both osteoinduction and osteoconductive features.

Medienart:

E-Artikel

Erscheinungsjahr:

2013

Erschienen:

2013

Enthalten in:

Zur Gesamtaufnahme - volume:28

Enthalten in:

Journal of biomaterials applications - 28(2013), 3 vom: 01. Sept., Seite 343-53

Sprache:

Englisch

Beteiligte Personen:

Bulgin, Dmitry [VerfasserIn]
Irha, Ernest [VerfasserIn]
Hodzic, Enes [VerfasserIn]
Nemec, Boris [VerfasserIn]

Links:

Volltext

Themen:

β-tricalcium phosphate
9007-34-5
Absorbable atelocollagen
Aneurysmal bone cyst
Atelocollagen
Beta-tricalcium phosphate
Bone marrow derived mononuclear cells
Bone regeneration
Calcium Phosphates
Collagen
Journal Article
Mesenchymal stem cells
Research Support, Non-U.S. Gov't

Anmerkungen:

Date Completed 01.04.2014

Date Revised 27.08.2013

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1177/0885328212451047

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM218579799